FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Enalaprilat Injection, USP
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Hospira, Inc. (New 03/24/2020)

Company Contact Information:
844-646-4398

Presentation Posting Date Related Information
1.25 mg/mL; Single Dose Glass Fliptop Vial (NDC 00409-2122-01) 03/24/2020 Discontinuation of the manufacture of the drug.
2.5 mg/2 mL (1.25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2122-02) 03/24/2020 Discontinuation of the manufacture of the drug.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English